← Back to All Filings

CareTrust REIT Appoints Former CEO to Board of Directors

Low SignificanceOctober 27, 2025 at 9:01:58 AM EDT

CareTrust REIT, Inc.

$CTRE8-KCIK: 0001590717

Subscribe to track CTRE

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

CareTrust REIT Appoints Former CEO to Board of Directors

Company: CareTrust REIT, Inc. (CTRE) Form: 8-K | Filed: 2025-10-27 Significance: Low (Trading)

Insider: Gregory K. Stapley Title: Director (effective Jan 1, 2026) | Relationship: Director

Transaction: • Type: Director Appointment & Compensation Agreement • Details: This filing reports the appointment of a new director. No shares were transacted. Compensation includes an $85,000 annual cash retainer and a $145,000 annual restricted stock award.

Key Insight: CareTrust is bringing its co-founder and former President & CEO back to the company as a director, signaling a focus on leveraging his deep institutional knowledge.

Market Context: This is a corporate governance update rather than a direct trading signal. Mr. Stapley is also the brother-in-law of the current CEO, David Sedgwick.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: CareTrust REIT, Inc. (CTRE)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: CareTrust REIT has appointed its co-founder and former CEO, Gregory K. Stapley, to its Board of Directors, a move that strengthens the board with deep institutional and industry experience.
  • Market Impact: Neutral. This is a corporate governance event, not a market transaction, and is unlikely to have an immediate impact on the stock price.

Company Information

FieldValue
CompanyCareTrust REIT, Inc.
Ticker SymbolCTRE
CIK0001590717
IndustryReal Estate Investment Trusts

Insider Information

FieldValue
NameGregory K. Stapley
CIKnull
Title/PositionDirector (effective January 1, 2026)
RelationshipDirector

Transaction Details

This Form 8-K reports a corporate event, not an insider trade. On October 21, 2025, the company appointed Gregory K. Stapley to the Board. In connection with his appointment, he will receive an annual cash retainer of $85,000 and an annual grant of restricted stock awards valued at $145,000. No shares were transacted as part of this filing.

FieldValue
Form Type8-K
Transaction Date2025-10-21
Transaction Codenull
Security Typenull
Shares Involvednull
Price Per Sharenull
Total Valuenull
Shares Owned Afternull
Ownership Typenull

Financial Impact Assessment

Transaction Materiality

As this filing does not report a specific stock transaction, a materiality analysis based on market capitalization or shares outstanding is not applicable. The financial impact is limited to the future compensation expenses for the new director.

Impact Evaluation

  • Market Cap Context: CareTrust REIT is a mid-cap company with a market capitalization of $7.78 billion. The director compensation package is standard for a company of this size and does not represent a material financial event.
  • Ownership Concentration: The filing does not disclose Mr. Stapley's current holdings, if any. The future stock grant of $145,000 is a small fraction of the company's total shares outstanding (218,125,322) and will have a negligible dilution impact.
  • Transaction Significance: The significance of this event is rooted in corporate governance, not trading. The appointment of a founder and former CEO is a notable event that brings significant historical context and expertise back to the board.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Director appointments are typically neutral events unless they signal a major strategic shift or a response to activist pressure. This appointment appears to be a strategic addition of a seasoned expert and is likely to be viewed neutrally or slightly positively by the market.

Volume & Sentiment

  • Expected Volume Impact: Minimal. This type of news does not typically drive significant trading volume.
  • Sentiment Indicator: Neutral. The return of a founder is generally a sign of stability and confidence.

Investment Insights

Positive Market Indicators

  • Re-engagement of a successful founder and former CEO can be seen as a positive for long-term strategy and governance.
  • Reinforces the company's leadership foundation with deep industry and company-specific experience.

Risk Factors

  • The filing notes a family relationship (Mr. Stapley is the brother-in-law of the current CEO). While disclosed and not uncommon, such relationships can raise questions about board independence for some investors.

Key Takeaways

  1. Governance, Not Trading: This is a corporate governance filing, not an insider trade. The primary signal is about leadership and board composition.
  2. Founder Returns: Gregory K. Stapley, a co-founder and the former CEO who led the company from its 2014 inception until 2022, is rejoining as a director.
  3. Standard Compensation: The compensation package is in line with typical director remuneration and does not constitute a material financial event for the company.

Additional Context

Transaction Notes

  • Timing: The appointment is effective January 1, 2026.
  • Special Circumstances: The filing explicitly states Mr. Stapley is the brother-in-law of David Sedgwick, the company's President and CEO.
Topics:#SECFiling#Form8K#CTRE#CareTrustREIT#CorporateGovernance#BoardofDirectors#REIT#HealthcareREIT#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.